Literature DB >> 7911142

Serotonin in panic disorder and social phobia.

D V Sheehan1, B A Raj, R R Trehan, E L Knapp.   

Abstract

The role of serotonin in psychiatry has been the focus of speculation for several decades. The literature since 1966 is reviewed (and referenced) and five organizing questions are identified: (1) What are the major hypotheses regarding the involvement of the serotonin system in panic disorder? (2) Is there a serotonin system defect associated with panic disorder? (3) Is a serotonin system defect the cause of panic disorder? (4) Are the 5-HT1A agonists and the 5-HT2 antagonists effective in this condition? (5) Are serotonin selective uptake inhibitors (SSUIs) effective in panic disorder via the serotonin system or some other mechanism? Though the role of the serotonin system in panic disorder and social phobia is uncertain there is increasing agreement that SSUIs effectively treat panic disorder but further double-blind placebo-controlled studies are needed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7911142     DOI: 10.1097/00004850-199311002-00010

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  9 in total

1.  ROCK inhibition produces anxiety-related behaviors in mice.

Authors:  Akiyoshi Saitoh; Mitsuhiko Yamada; Misa Yamada; Shinya Kobayashi; Noritaka Hirose; Kazuo Honda; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2006-07-13       Impact factor: 4.530

2.  Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.

Authors:  E Leinonen; U Lepola; H Koponen; J Turtonen; A Wade; H Lehto
Journal:  J Psychiatry Neurosci       Date:  2000-01       Impact factor: 6.186

3.  Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

Authors:  C Sánchez; E Meier
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

4.  A functional Tph2 C1473G polymorphism causes an anxiety phenotype via compensatory changes in the serotonergic system.

Authors:  Stefan M Berger; Tillmann Weber; Stephanie Perreau-Lenz; Miriam A Vogt; Sarah E Gartside; Christiane Maser-Gluth; Laurence Lanfumey; Peter Gass; Rainer Spanagel; Dusan Bartsch
Journal:  Neuropsychopharmacology       Date:  2012-04-11       Impact factor: 7.853

Review 5.  Psychophysiological hypotheses regarding multiple chemical sensitivity syndrome.

Authors:  P M Lehrer
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

6.  Association Study between 5-HT1A Receptor Gene C(-1019)G Polymorphism and Panic Disorder in a Korean Population.

Authors:  Won-Seok Choi; Bun-Hee Lee; Jong-Chul Yang; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2010-04-06       Impact factor: 2.505

7.  Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats.

Authors:  Shilpa Ravinder; Anup G Pillai; Sumantra Chattarji
Journal:  Front Behav Neurosci       Date:  2011-12-28       Impact factor: 3.558

8.  A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatment.

Authors:  S Ravinder; N S Burghardt; R Brodsky; E P Bauer; S Chattarji
Journal:  Transl Psychiatry       Date:  2013-01-15       Impact factor: 6.222

9.  Comparative Distribution of Relaxin-3 Inputs and Calcium-Binding Protein-Positive Neurons in Rat Amygdala.

Authors:  Fabio N Santos; Celia W Pereira; Ana M Sánchez-Pérez; Marcos Otero-García; Sherie Ma; Andrew L Gundlach; Francisco E Olucha-Bordonau
Journal:  Front Neuroanat       Date:  2016-04-07       Impact factor: 3.856

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.